← FDA DRUG APPROVALS

FDA ANDA · ANDA091542

TOPOTECAN HYDROCHLORIDE

Sponsor: RISING

APPLICATION
ANDA091542
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-28
LATEST ACTION
2021-03-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TOPOTECAN HYDROCHLORIDEDiscontinued
TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2021-03-19Manufacturing (CMC) · Supplement 7 · standardAP
2021-03-19Labeling · Supplement 6 · standardAP
2015-12-03Labeling · Supplement 1 · standardAP
2015-12-03Labeling · Supplement 4 · standardAP
2012-08-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →